Javier Loscertales

5PUBLICATIONS
32CO-AUTHORS
AutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursNatural language processing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 13, 2026
Clinical Implications of Immune Dysfunction in Chronic Lymphocytic Leukemia.

|Aug 27, 2025
The impact of fitness and dose intensity on clinical outcomes with venetoclax-obinutuzumab in CLL.

Othman Al-Sawaf, Moritz Fürstenau, Adam Giza

|Jul 30, 2025
Pharmacogenetic Biomarkers of Ibrutinib Response and Toxicity in Chronic Lymphocytic Leukemia: Insights from an Observational Study.

Noelia Pérez-Gómez, Antonio Sanz-Solas, Beatriz Cuevas

|Dec 17, 2024
Real-World Evidence on Adverse Events and Healthcare Resource Utilization in Patients with Chronic Lymphocytic Leukaemia in Spain Using Natural Language Processing: The SRealCLL Study.

Pau Abrisqueta-Costa, José Antonio García-Marco, Antonio Gutiérrez

|Jul 31, 2024
Venetoclax-obinutuzumab for previously untreated chronic lymphocytic leukemia: 6-year results of the randomized phase 3 CLL14 study.

Othman Al-Sawaf, Sandra Robrecht, Can Zhang

Pageof 1

Frequent Collaborators

2 joint publications

Othman Al-Sawaf

2 joint publications

Carsten Utoft Niemann

1 joint publications

Kirsten Fischer

1 joint publications

Pau Abrisqueta-Costa